These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 24551085)

  • 1. Evaluation of candidate nephropathy susceptibility genes in a genome-wide association study of African American diabetic kidney disease.
    Palmer ND; Ng MC; Hicks PJ; Mudgal P; Langefeld CD; Freedman BI; Bowden DW
    PLoS One; 2014; 9(2):e88273. PubMed ID: 24551085
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential effects of MYH9 and APOL1 risk variants on FRMD3 Association with Diabetic ESRD in African Americans.
    Freedman BI; Langefeld CD; Lu L; Divers J; Comeau ME; Kopp JB; Winkler CA; Nelson GW; Johnson RC; Palmer ND; Hicks PJ; Bostrom MA; Cooke JN; McDonough CW; Bowden DW
    PLoS Genet; 2011 Jun; 7(6):e1002150. PubMed ID: 21698141
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of coding variants identified from exome sequencing resources for association with diabetic and non-diabetic nephropathy in African Americans.
    Bailey JNC; Palmer ND; Ng MCY; Bonomo JA; Hicks PJ; Hester JM; Langefeld CD; Freedman BI; Bowden DW
    Hum Genet; 2014 Jun; 133(6):769-779. PubMed ID: 24385048
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Re-Sequencing of the APOL1-APOL4 and MYH9 Gene Regions in African Americans Does Not Identify Additional Risks for CKD Progression.
    Hawkins GA; Friedman DJ; Lu L; McWilliams DR; Chou JW; Sajuthi S; Divers J; Parekh RS; Li M; Genovese G; Pollack MR; Hicks PJ; Bowden DW; Ma L; Freedman BI; Langefeld CD
    Am J Nephrol; 2015; 42(2):99-106. PubMed ID: 26343748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Missense mutations in the APOL1 gene are highly associated with end stage kidney disease risk previously attributed to the MYH9 gene.
    Tzur S; Rosset S; Shemer R; Yudkovsky G; Selig S; Tarekegn A; Bekele E; Bradman N; Wasser WG; Behar DM; Skorecki K
    Hum Genet; 2010 Sep; 128(3):345-50. PubMed ID: 20635188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sickle cell trait is not independently associated with susceptibility to end-stage renal disease in African Americans.
    Hicks PJ; Langefeld CD; Lu L; Bleyer AJ; Divers J; Nachman PH; Derebail VK; Bowden DW; Freedman BI
    Kidney Int; 2011 Dec; 80(12):1339-43. PubMed ID: 21849968
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coding variants in nephrin (NPHS1) and susceptibility to nephropathy in African Americans.
    Bonomo JA; Ng MC; Palmer ND; Keaton JM; Larsen CP; Hicks PJ; ; Langefeld CD; Freedman BI; Bowden DW
    Clin J Am Soc Nephrol; 2014 Aug; 9(8):1434-40. PubMed ID: 24948143
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene-gene interactions in APOL1-associated nephropathy.
    Divers J; Palmer ND; Lu L; Langefeld CD; Rocco MV; Hicks PJ; Murea M; Ma L; Bowden DW; Freedman BI
    Nephrol Dial Transplant; 2014 Mar; 29(3):587-94. PubMed ID: 24157943
    [TBL] [Abstract][Full Text] [Related]  

  • 9. African ancestry allelic variation at the MYH9 gene contributes to increased susceptibility to non-diabetic end-stage kidney disease in Hispanic Americans.
    Behar DM; Rosset S; Tzur S; Selig S; Yudkovsky G; Bercovici S; Kopp JB; Winkler CA; Nelson GW; Wasser WG; Skorecki K
    Hum Mol Genet; 2010 May; 19(9):1816-27. PubMed ID: 20144966
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of trypanolytic ApoL1 variants with kidney disease in African Americans.
    Genovese G; Friedman DJ; Ross MD; Lecordier L; Uzureau P; Freedman BI; Bowden DW; Langefeld CD; Oleksyk TK; Uscinski Knob AL; Bernhardy AJ; Hicks PJ; Nelson GW; Vanhollebeke B; Winkler CA; Kopp JB; Pays E; Pollak MR
    Science; 2010 Aug; 329(5993):841-5. PubMed ID: 20647424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Target organ damage in African American hypertension: role of APOL1.
    Freedman BI; Murea M
    Curr Hypertens Rep; 2012 Feb; 14(1):21-8. PubMed ID: 22068337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MYH9 and APOL1 are both associated with sickle cell disease nephropathy.
    Ashley-Koch AE; Okocha EC; Garrett ME; Soldano K; De Castro LM; Jonassaint JC; Orringer EP; Eckman JR; Telen MJ
    Br J Haematol; 2011 Nov; 155(3):386-94. PubMed ID: 21910715
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-muscle myosin heavy chain 9 gene MYH9 associations in African Americans with clinically diagnosed type 2 diabetes mellitus-associated ESRD.
    Freedman BI; Hicks PJ; Bostrom MA; Comeau ME; Divers J; Bleyer AJ; Kopp JB; Winkler CA; Nelson GW; Langefeld CD; Bowden DW
    Nephrol Dial Transplant; 2009 Nov; 24(11):3366-71. PubMed ID: 19567477
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The apolipoprotein L1 (APOL1) gene and nondiabetic nephropathy in African Americans.
    Freedman BI; Kopp JB; Langefeld CD; Genovese G; Friedman DJ; Nelson GW; Winkler CA; Bowden DW; Pollak MR
    J Am Soc Nephrol; 2010 Sep; 21(9):1422-6. PubMed ID: 20688934
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of kidney structure-related gene variants with type 2 diabetes-attributed end-stage kidney disease in African Americans.
    Guan M; Ma J; Keaton JM; Dimitrov L; Mudgal P; Stromberg M; Bonomo JA; Hicks PJ; Freedman BI; Bowden DW; Ng MC
    Hum Genet; 2016 Nov; 135(11):1251-1262. PubMed ID: 27461219
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A genome-wide association study for diabetic nephropathy genes in African Americans.
    McDonough CW; Palmer ND; Hicks PJ; Roh BH; An SS; Cooke JN; Hester JM; Wing MR; Bostrom MA; Rudock ME; Lewis JP; Talbert ME; Blevins RA; Lu L; Ng MC; Sale MM; Divers J; Langefeld CD; Freedman BI; Bowden DW
    Kidney Int; 2011 Mar; 79(5):563-72. PubMed ID: 21150874
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic variation in APOL1 and MYH9 genes is associated with chronic kidney disease among Nigerians.
    Tayo BO; Kramer H; Salako BL; Gottesman O; McKenzie CA; Ogunniyi A; Bottinger EP; Cooper RS
    Int Urol Nephrol; 2013 Apr; 45(2):485-94. PubMed ID: 22956460
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lack of Association of the APOL1 G3 Haplotype in African Americans with ESRD.
    Palmer ND; Ng MC; Langefeld CD; Divers J; Lea JP; Okusa MD; Kimberly RP; Bowden DW; Freedman BI
    J Am Soc Nephrol; 2015 May; 26(5):1021-5. PubMed ID: 25249559
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polymorphisms in MYH9 are associated with diabetic nephropathy in European Americans.
    Cooke JN; Bostrom MA; Hicks PJ; Ng MC; Hellwege JN; Comeau ME; Divers J; Langefeld CD; Freedman BI; Bowden DW
    Nephrol Dial Transplant; 2012 Apr; 27(4):1505-11. PubMed ID: 21968013
    [TBL] [Abstract][Full Text] [Related]  

  • 20. APOL1 allelic variants are associated with lower age of dialysis initiation and thereby increased dialysis vintage in African and Hispanic Americans with non-diabetic end-stage kidney disease.
    Tzur S; Rosset S; Skorecki K; Wasser WG
    Nephrol Dial Transplant; 2012 Apr; 27(4):1498-505. PubMed ID: 22357707
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.